- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0116394

Speciality Nectar Pharma India Private Limited
About Speciality Nectar Pharma India Private Limited
Data last updated:
Speciality Nectar Pharma India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 21 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2020PTC133911.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Selvarasu and Ramar Vijayakumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 155/1 North Facing First Floor L B Road Thiruvanmiyur, Chennai, Tamil Nadu, India – 600041.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.67 Cr, a decline of 34% compared to the previous year. For the same year it recorded a net profit of ₹63,548 (net margin 0.2%) and EBITDA of ₹5.1 Lakh (EBITDA margin 1.9%).
As per MCA filings, the company has open charges of ₹39.45 Lakh on record.
Speciality Nectar Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0116394).
Company details
Recognitions & Rankings of Speciality Nectar Pharma India
Contact details
Speciality Nectar Pharma India Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered Address155/1 North Facing First Floor L B Road Thiruvanmiyur, Chennai, Tamil Nadu, India – 600041
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Speciality Nectar Pharma India is trade. In detail, this covers wholesale trading and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Speciality Nectar Pharma India Private Limited, buy the company report.
Financials of Speciality Nectar Pharma India Private Limited
FY 2023 filings availableSpeciality Nectar Pharma India Private Limited reported revenue of ₹2.67 Cr (down 34% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 34% in the latest year. EBITDA fell 27% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.1 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹63,548 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.9% | |||
| Net Profit Margin | 0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Speciality Nectar Pharma India Private Limited, buy the company report.
Board of directors of Speciality Nectar Pharma India Private Limited
Speciality Nectar Pharma India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Selvarasu Also directs: Speciality Medicine Sales Private Limited | Director | 21 Jan 2020 | 6 Years 9 Months | Current |
| Ramar Vijayakumar Also directs: Speciality Medicine Sales Private Limited | Director | 21 Jan 2020 | 6 Years 9 Months | Current |
| Viswanathan Ramar Also directs: Speciality Medicine Sales Private Limited | Director | 21 Jan 2020 | 6 Years 9 Months | Current |
Peer comparison
Speciality Nectar Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amico Strong Bond Private Limited | ₹2.67 Cr (FY 2024) | 19.0% | Mumbai, Maharashtra, India | |||
| Medcare Marketing Private Limited | ₹2.67 Cr (FY 2022) | 1.0% | Kochi, Kerala, India | |||
| Prime Lumbers Private Limited | ₹2.67 Cr (FY 2021) | 17.0% | Kutch, Gujarat, India | |||
| Pooranchand Refrigeration Private Limited | ₹2.67 Cr (FY 2025) | 198.0% | Agra, Uttar Pradesh, India | |||
| Benier Automotive (I) Private Limited | ₹2.67 Cr (FY 2024) | 292.0% | Mira Road, Maharashtra, India | |||
| Speciality Nectar Pharma India Private Limitedthis company | ₹2.67 Cr (FY 2023) | ₹63,548 | 0.2% | -34.0% | Chennai, Tamil Nadu, India | |
| Sois Formulations Private Limited | ₹2.67 Cr (FY 2025) | -23.0% | Ambala Cantt, Haryana, India | |||
| Ganga Coffee Curing Works Limited | ₹2.67 Cr (FY 2016) | 46.0% | Karnatakaan, Karnataka, India | |||
| Seabuck Ayurveda Private Limited | ₹2.67 Cr (FY 2018) | 43.0% | New Delhi, Delhi, India | |||
| Cameo Health Care (India) Private Limited | ₹2.67 Cr (FY 2025) | 40.0% | Alto Porvorim, Goa, India | |||
| People Hire Purchase & Trading Co Pvt Ltd | ₹2.67 Cr (FY 2019) | -2.0% | Shillong, Meghalaya, India |
To see the full peer comparison of Speciality Nectar Pharma India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jan 2021 | 100429803 | Others | ₹39.45 Lakh | Open |
To see the full charge records of Speciality Nectar Pharma India Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Speciality Nectar Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Speciality Nectar Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Speciality Nectar Pharma India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Speciality Nectar Pharma India Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Ramar Vijayakumar was appointed as Director on 21 Jan 2020.
Frequently asked questions
Speciality Nectar Pharma India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialty, within the trading industry. It was incorporated on 21 January 2020 (6+ years old) and is registered under CIN U51909TN2020PTC133911.
Speciality Nectar Pharma India has 3 current directors:
- Selvarasu - Director
- Ramar Vijayakumar - Director
- Viswanathan Ramar - Director
The latest financial statements of Speciality Nectar Pharma India on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Speciality Nectar Pharma India is U51909TN2020PTC133911. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Speciality Nectar Pharma India was incorporated on 21 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Speciality Nectar Pharma India by revenue are Amico Strong Bond Private Limited, Medcare Marketing Private Limited, Prime Lumbers Private Limited, Pooranchand Refrigeration Private Limited, Benier Automotive (I) Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ramar Vijayakumar was appointed as Director on 21 Jan 2020. Selvarasu was appointed as Director on 21 Jan 2020. Viswanathan Ramar was appointed as Director on 21 Jan 2020.
Yes, Speciality Nectar Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0116394).
The registered office of Speciality Nectar Pharma India is at 1551 North Facing First Floor L B Road Thiruvanmiyur, Chennai, Tamil Nadu, India – 600041.
Speciality Nectar Pharma India operates in the trading industry, in the specialty segment.
Speciality Nectar Pharma India has open charges of ₹39.45 Lakh and no satisfied charges on record as per latest MCA filings.

